ARMISTICE CAPITAL, LLC - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 48 filers reported holding OVID THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ARMISTICE CAPITAL, LLC ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$3,151,000
-18.6%
1,780,000
+11.2%
0.17%
-41.3%
Q4 2018$3,872,0001,600,0000.29%
Other shareholders
OVID THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
TLS Advisors LLC 1,490,534$2,77213.66%
Madison Avenue Partners, LP 2,721,051$5,061,1550.90%
Rubric Capital Management LP 6,828,065$12,700,2010.55%
BVF INC/IL 6,851,051$12,742,9550.54%
CHI Advisors LLC 864,822$1,608,5690.43%
EcoR1 Capital, LLC 6,117,400$11,378,3640.35%
Artal Group S.A. 2,500,000$4,6500.26%
Tejara Capital Ltd 107,491$199,9330.12%
Oasis Management Co Ltd. 270,000$502,2000.10%
DCF Advisers, LLC 70,264$130,6910.09%
View complete list of OVID THERAPEUTICS INC shareholders